nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—L-Glutamine—Vigabatrin—epilepsy syndrome	0.385	1	CrCrCtD
L-Arginine—NOS2—epilepsy syndrome	0.299	1	CbGaD
L-Arginine—ARG2—hindbrain—epilepsy syndrome	0.00255	0.0489	CbGeAlD
L-Arginine—ASS1—Protriptyline—Carbamazepine—epilepsy syndrome	0.00209	1	CbGdCrCtD
L-Arginine—AZIN2—medulla oblongata—epilepsy syndrome	0.00196	0.0375	CbGeAlD
L-Arginine—AZIN2—midbrain—epilepsy syndrome	0.00179	0.0343	CbGeAlD
L-Arginine—AZIN2—spinal cord—epilepsy syndrome	0.00174	0.0335	CbGeAlD
L-Arginine—SLC7A4—head—epilepsy syndrome	0.00162	0.031	CbGeAlD
L-Arginine—SLC7A4—nervous system—epilepsy syndrome	0.00153	0.0294	CbGeAlD
L-Arginine—SLC7A1—telencephalon—epilepsy syndrome	0.00152	0.0291	CbGeAlD
L-Arginine—SLC7A4—central nervous system—epilepsy syndrome	0.00148	0.0283	CbGeAlD
L-Arginine—ARG2—brainstem—epilepsy syndrome	0.00146	0.028	CbGeAlD
L-Arginine—ASL—head—epilepsy syndrome	0.00144	0.0276	CbGeAlD
L-Arginine—ARG2—forebrain—epilepsy syndrome	0.00141	0.0271	CbGeAlD
L-Arginine—AZIN2—cerebellum—epilepsy syndrome	0.00138	0.0265	CbGeAlD
L-Arginine—ASL—nervous system—epilepsy syndrome	0.00137	0.0262	CbGeAlD
L-Arginine—ASL—central nervous system—epilepsy syndrome	0.00131	0.0252	CbGeAlD
L-Arginine—ARG2—telencephalon—epilepsy syndrome	0.0013	0.0249	CbGeAlD
L-Arginine—ASL—cerebellum—epilepsy syndrome	0.00129	0.0247	CbGeAlD
L-Arginine—SLC7A4—brain—epilepsy syndrome	0.00117	0.0225	CbGeAlD
L-Arginine—L-Glutamine—QARS—epilepsy syndrome	0.00115	0.333	CrCbGaD
L-Arginine—AZIN2—brain—epilepsy syndrome	0.00112	0.0216	CbGeAlD
L-Arginine—ASL—brain—epilepsy syndrome	0.00104	0.02	CbGeAlD
L-Arginine—ARG2—medulla oblongata—epilepsy syndrome	0.00102	0.0196	CbGeAlD
L-Arginine—ASS1—forebrain—epilepsy syndrome	0.000988	0.019	CbGeAlD
L-Arginine—NOS3—forebrain—epilepsy syndrome	0.000985	0.0189	CbGeAlD
L-Arginine—SLC7A1—head—epilepsy syndrome	0.000944	0.0181	CbGeAlD
L-Arginine—ARG2—midbrain—epilepsy syndrome	0.000931	0.0179	CbGeAlD
L-Arginine—ASS1—telencephalon—epilepsy syndrome	0.000909	0.0174	CbGeAlD
L-Arginine—ARG2—spinal cord—epilepsy syndrome	0.000909	0.0174	CbGeAlD
L-Arginine—NOS3—telencephalon—epilepsy syndrome	0.000906	0.0174	CbGeAlD
L-Arginine—SLC7A1—nervous system—epilepsy syndrome	0.000895	0.0172	CbGeAlD
L-Arginine—SLC7A1—central nervous system—epilepsy syndrome	0.000862	0.0165	CbGeAlD
L-Arginine—SLC7A1—cerebellum—epilepsy syndrome	0.000842	0.0162	CbGeAlD
L-Arginine—ARG2—head—epilepsy syndrome	0.000808	0.0155	CbGeAlD
L-Arginine—L-Methionine—GLUL—epilepsy syndrome	0.000772	0.224	CrCbGaD
L-Arginine—ARG2—nervous system—epilepsy syndrome	0.000766	0.0147	CbGeAlD
L-Arginine—ARG2—central nervous system—epilepsy syndrome	0.000737	0.0141	CbGeAlD
L-Arginine—ARG2—cerebellum—epilepsy syndrome	0.00072	0.0138	CbGeAlD
L-Arginine—ASS1—medulla oblongata—epilepsy syndrome	0.000714	0.0137	CbGeAlD
L-Arginine—SLC7A1—brain—epilepsy syndrome	0.000684	0.0131	CbGeAlD
L-Arginine—ASS1—midbrain—epilepsy syndrome	0.000653	0.0125	CbGeAlD
L-Arginine—ASS1—spinal cord—epilepsy syndrome	0.000637	0.0122	CbGeAlD
L-Arginine—L-Citrulline—NOS1—epilepsy syndrome	0.000634	0.184	CrCbGaD
L-Arginine—ARG2—brain—epilepsy syndrome	0.000585	0.0112	CbGeAlD
L-Arginine—ASS1—head—epilepsy syndrome	0.000566	0.0109	CbGeAlD
L-Arginine—NOS3—head—epilepsy syndrome	0.000564	0.0108	CbGeAlD
L-Arginine—L-Glutamine—GLUL—epilepsy syndrome	0.000562	0.163	CrCbGaD
L-Arginine—ASS1—nervous system—epilepsy syndrome	0.000537	0.0103	CbGeAlD
L-Arginine—NOS3—nervous system—epilepsy syndrome	0.000535	0.0103	CbGeAlD
L-Arginine—ASS1—central nervous system—epilepsy syndrome	0.000517	0.00992	CbGeAlD
L-Arginine—NOS3—central nervous system—epilepsy syndrome	0.000515	0.00988	CbGeAlD
L-Arginine—ASS1—cerebellum—epilepsy syndrome	0.000505	0.00969	CbGeAlD
L-Arginine—ASS1—brain—epilepsy syndrome	0.00041	0.00787	CbGeAlD
L-Arginine—NOS3—brain—epilepsy syndrome	0.000409	0.00785	CbGeAlD
L-Arginine—SLC22A4—spinal cord—epilepsy syndrome	0.000405	0.00778	CbGeAlD
L-Arginine—SLC16A10—cerebellum—epilepsy syndrome	0.000361	0.00692	CbGeAlD
L-Arginine—Haematuria—Zonisamide—epilepsy syndrome	0.00036	0.00295	CcSEcCtD
L-Arginine—Anorexia—Rufinamide—epilepsy syndrome	0.000358	0.00294	CcSEcCtD
L-Arginine—Hypoaesthesia—Diazepam—epilepsy syndrome	0.000356	0.00291	CcSEcCtD
L-Arginine—Lethargy—Valproic Acid—epilepsy syndrome	0.00035	0.00287	CcSEcCtD
L-Arginine—Sweating—Phenytoin—epilepsy syndrome	0.000346	0.00284	CcSEcCtD
L-Arginine—Haematuria—Oxcarbazepine—epilepsy syndrome	0.000342	0.00281	CcSEcCtD
L-Arginine—Hyperhidrosis—Lacosamide—epilepsy syndrome	0.000341	0.0028	CcSEcCtD
L-Arginine—L-Citrulline—NOS2—epilepsy syndrome	0.000333	0.0965	CrCbGaD
L-Arginine—Hyperhidrosis—Clobazam—epilepsy syndrome	0.000331	0.00271	CcSEcCtD
L-Arginine—Haematuria—Carbamazepine—epilepsy syndrome	0.000329	0.00269	CcSEcCtD
L-Arginine—Decreased appetite—Rufinamide—epilepsy syndrome	0.000327	0.00268	CcSEcCtD
L-Arginine—Anorexia—Clobazam—epilepsy syndrome	0.000327	0.00268	CcSEcCtD
L-Arginine—Hypoaesthesia—Clonazepam—epilepsy syndrome	0.000325	0.00266	CcSEcCtD
L-Arginine—Vomiting—Amobarbital—epilepsy syndrome	0.000325	0.00266	CcSEcCtD
L-Arginine—Swelling—Gabapentin—epilepsy syndrome	0.000323	0.00264	CcSEcCtD
L-Arginine—Hypoaesthesia—Phenytoin—epilepsy syndrome	0.000322	0.00264	CcSEcCtD
L-Arginine—Rash—Amobarbital—epilepsy syndrome	0.000322	0.00264	CcSEcCtD
L-Arginine—Dermatitis—Amobarbital—epilepsy syndrome	0.000322	0.00263	CcSEcCtD
L-Arginine—SLC22A4—cerebellum—epilepsy syndrome	0.000321	0.00617	CbGeAlD
L-Arginine—Flushing—Felbamate—epilepsy syndrome	0.000321	0.00263	CcSEcCtD
L-Arginine—Hypoaesthesia—Oxcarbazepine—epilepsy syndrome	0.000321	0.00263	CcSEcCtD
L-Arginine—Headache—Amobarbital—epilepsy syndrome	0.00032	0.00262	CcSEcCtD
L-Arginine—Sweating—Lamotrigine—epilepsy syndrome	0.000319	0.00262	CcSEcCtD
L-Arginine—Haematuria—Lamotrigine—epilepsy syndrome	0.000318	0.0026	CcSEcCtD
L-Arginine—Lethargy—Pregabalin—epilepsy syndrome	0.000317	0.0026	CcSEcCtD
L-Arginine—Vomiting—Primidone—epilepsy syndrome	0.000313	0.00256	CcSEcCtD
L-Arginine—Rash—Primidone—epilepsy syndrome	0.00031	0.00254	CcSEcCtD
L-Arginine—Dermatitis—Primidone—epilepsy syndrome	0.00031	0.00254	CcSEcCtD
L-Arginine—Headache—Primidone—epilepsy syndrome	0.000308	0.00252	CcSEcCtD
L-Arginine—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000305	0.0025	CcSEcCtD
L-Arginine—Nausea—Amobarbital—epilepsy syndrome	0.000303	0.00248	CcSEcCtD
L-Arginine—Flushing—Clonazepam—epilepsy syndrome	0.000303	0.00248	CcSEcCtD
L-Arginine—SLC22A5—medulla oblongata—epilepsy syndrome	0.000301	0.00577	CbGeAlD
L-Arginine—Flushing—Oxcarbazepine—epilepsy syndrome	0.000299	0.00245	CcSEcCtD
L-Arginine—Decreased appetite—Clobazam—epilepsy syndrome	0.000298	0.00244	CcSEcCtD
L-Arginine—Hypoaesthesia—Lamotrigine—epilepsy syndrome	0.000297	0.00244	CcSEcCtD
L-Arginine—Nausea—Primidone—epilepsy syndrome	0.000292	0.00239	CcSEcCtD
L-Arginine—Lethargy—Gabapentin—epilepsy syndrome	0.000291	0.00238	CcSEcCtD
L-Arginine—Flushing—Carbamazepine—epilepsy syndrome	0.000287	0.00235	CcSEcCtD
L-Arginine—Anaphylactic shock—Propofol—epilepsy syndrome	0.000284	0.00232	CcSEcCtD
L-Arginine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000282	0.00231	CcSEcCtD
L-Arginine—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000278	0.00227	CcSEcCtD
L-Arginine—Flushing—Lamotrigine—epilepsy syndrome	0.000277	0.00227	CcSEcCtD
L-Arginine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000277	0.00227	CcSEcCtD
L-Arginine—Tachycardia—Propofol—epilepsy syndrome	0.000277	0.00227	CcSEcCtD
L-Arginine—Vomiting—Trimethadione—epilepsy syndrome	0.000275	0.00225	CcSEcCtD
L-Arginine—SLC22A5—midbrain—epilepsy syndrome	0.000275	0.00527	CbGeAlD
L-Arginine—Hyperhidrosis—Propofol—epilepsy syndrome	0.000274	0.00225	CcSEcCtD
L-Arginine—Rash—Trimethadione—epilepsy syndrome	0.000273	0.00224	CcSEcCtD
L-Arginine—Dermatitis—Trimethadione—epilepsy syndrome	0.000273	0.00223	CcSEcCtD
L-Arginine—Headache—Trimethadione—epilepsy syndrome	0.000271	0.00222	CcSEcCtD
L-Arginine—Tachycardia—Midazolam—epilepsy syndrome	0.000271	0.00222	CcSEcCtD
L-Arginine—SLC22A5—spinal cord—epilepsy syndrome	0.000268	0.00515	CbGeAlD
L-Arginine—Decreased appetite—Acetazolamide—epilepsy syndrome	0.000266	0.00218	CcSEcCtD
L-Arginine—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000265	0.00217	CcSEcCtD
L-Arginine—Anorexia—Levetiracetam—epilepsy syndrome	0.000261	0.00214	CcSEcCtD
L-Arginine—SLC22A4—brain—epilepsy syndrome	0.000261	0.00501	CbGeAlD
L-Arginine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.00026	0.00213	CcSEcCtD
L-Arginine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.000258	0.00212	CcSEcCtD
L-Arginine—Nausea—Trimethadione—epilepsy syndrome	0.000257	0.00211	CcSEcCtD
L-Arginine—Hyperhidrosis—Fosphenytoin—epilepsy syndrome	0.000256	0.0021	CcSEcCtD
L-Arginine—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000254	0.00208	CcSEcCtD
L-Arginine—Sweating—Valproic Acid—epilepsy syndrome	0.000254	0.00208	CcSEcCtD
L-Arginine—Anorexia—Fosphenytoin—epilepsy syndrome	0.000252	0.00207	CcSEcCtD
L-Arginine—Tachycardia—Diazepam—epilepsy syndrome	0.000248	0.00203	CcSEcCtD
L-Arginine—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000246	0.00201	CcSEcCtD
L-Arginine—Hyperhidrosis—Diazepam—epilepsy syndrome	0.000245	0.00201	CcSEcCtD
L-Arginine—Lethargy—Topiramate—epilepsy syndrome	0.000244	0.002	CcSEcCtD
L-Arginine—Vomiting—Phenobarbital—epilepsy syndrome	0.000244	0.002	CcSEcCtD
L-Arginine—Anorexia—Diazepam—epilepsy syndrome	0.000242	0.00198	CcSEcCtD
L-Arginine—Rash—Phenobarbital—epilepsy syndrome	0.000242	0.00198	CcSEcCtD
L-Arginine—Dermatitis—Phenobarbital—epilepsy syndrome	0.000241	0.00198	CcSEcCtD
L-Arginine—Headache—Phenobarbital—epilepsy syndrome	0.00024	0.00197	CcSEcCtD
L-Arginine—Tachycardia—Felbamate—epilepsy syndrome	0.00024	0.00197	CcSEcCtD
L-Arginine—Vomiting—Rufinamide—epilepsy syndrome	0.000239	0.00196	CcSEcCtD
L-Arginine—Decreased appetite—Levetiracetam—epilepsy syndrome	0.000238	0.00195	CcSEcCtD
L-Arginine—Hyperhidrosis—Felbamate—epilepsy syndrome	0.000238	0.00195	CcSEcCtD
L-Arginine—Rash—Rufinamide—epilepsy syndrome	0.000237	0.00194	CcSEcCtD
L-Arginine—Dermatitis—Rufinamide—epilepsy syndrome	0.000237	0.00194	CcSEcCtD
L-Arginine—Hypoaesthesia—Valproic Acid—epilepsy syndrome	0.000236	0.00194	CcSEcCtD
L-Arginine—Headache—Rufinamide—epilepsy syndrome	0.000236	0.00193	CcSEcCtD
L-Arginine—Tachycardia—Zonisamide—epilepsy syndrome	0.000235	0.00192	CcSEcCtD
L-Arginine—Anorexia—Felbamate—epilepsy syndrome	0.000234	0.00192	CcSEcCtD
L-Arginine—Hyperhidrosis—Zonisamide—epilepsy syndrome	0.000233	0.00191	CcSEcCtD
L-Arginine—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000232	0.0019	CcSEcCtD
L-Arginine—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.00023	0.00189	CcSEcCtD
L-Arginine—Decreased appetite—Fosphenytoin—epilepsy syndrome	0.00023	0.00188	CcSEcCtD
L-Arginine—Sweating—Pregabalin—epilepsy syndrome	0.000229	0.00188	CcSEcCtD
L-Arginine—Anorexia—Zonisamide—epilepsy syndrome	0.000229	0.00188	CcSEcCtD
L-Arginine—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.000229	0.00188	CcSEcCtD
L-Arginine—Haematuria—Pregabalin—epilepsy syndrome	0.000228	0.00187	CcSEcCtD
L-Arginine—Nausea—Phenobarbital—epilepsy syndrome	0.000228	0.00186	CcSEcCtD
L-Arginine—Tachycardia—Clonazepam—epilepsy syndrome	0.000226	0.00185	CcSEcCtD
L-Arginine—Tachycardia—Phenytoin—epilepsy syndrome	0.000225	0.00184	CcSEcCtD
L-Arginine—Vomiting—Lacosamide—epilepsy syndrome	0.000225	0.00184	CcSEcCtD
L-Arginine—Decreased appetite—Vigabatrin—epilepsy syndrome	0.000224	0.00184	CcSEcCtD
L-Arginine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000224	0.00183	CcSEcCtD
L-Arginine—Nausea—Rufinamide—epilepsy syndrome	0.000223	0.00183	CcSEcCtD
L-Arginine—Rash—Lacosamide—epilepsy syndrome	0.000223	0.00182	CcSEcCtD
L-Arginine—Hyperhidrosis—Phenytoin—epilepsy syndrome	0.000223	0.00182	CcSEcCtD
L-Arginine—Dermatitis—Lacosamide—epilepsy syndrome	0.000222	0.00182	CcSEcCtD
L-Arginine—Hyperhidrosis—Oxcarbazepine—epilepsy syndrome	0.000221	0.00181	CcSEcCtD
L-Arginine—Headache—Lacosamide—epilepsy syndrome	0.000221	0.00181	CcSEcCtD
L-Arginine—Anorexia—Clonazepam—epilepsy syndrome	0.000221	0.00181	CcSEcCtD
L-Arginine—Decreased appetite—Diazepam—epilepsy syndrome	0.000221	0.00181	CcSEcCtD
L-Arginine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.00022	0.0018	CcSEcCtD
L-Arginine—Anorexia—Phenytoin—epilepsy syndrome	0.000219	0.0018	CcSEcCtD
L-Arginine—Anorexia—Oxcarbazepine—epilepsy syndrome	0.000218	0.00179	CcSEcCtD
L-Arginine—Vomiting—Clobazam—epilepsy syndrome	0.000218	0.00179	CcSEcCtD
L-Arginine—Rash—Clobazam—epilepsy syndrome	0.000216	0.00177	CcSEcCtD
L-Arginine—Dermatitis—Clobazam—epilepsy syndrome	0.000216	0.00177	CcSEcCtD
L-Arginine—Headache—Clobazam—epilepsy syndrome	0.000215	0.00176	CcSEcCtD
L-Arginine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000215	0.00176	CcSEcCtD
L-Arginine—Hypoaesthesia—Pregabalin—epilepsy syndrome	0.000214	0.00175	CcSEcCtD
L-Arginine—Decreased appetite—Felbamate—epilepsy syndrome	0.000214	0.00175	CcSEcCtD
L-Arginine—SLC22A5—cerebellum—epilepsy syndrome	0.000213	0.00408	CbGeAlD
L-Arginine—Hyperhidrosis—Carbamazepine—epilepsy syndrome	0.000212	0.00174	CcSEcCtD
L-Arginine—Sweating—Gabapentin—epilepsy syndrome	0.00021	0.00172	CcSEcCtD
L-Arginine—Nausea—Lacosamide—epilepsy syndrome	0.00021	0.00172	CcSEcCtD
L-Arginine—Anorexia—Carbamazepine—epilepsy syndrome	0.00021	0.00172	CcSEcCtD
L-Arginine—Haematuria—Gabapentin—epilepsy syndrome	0.000209	0.00171	CcSEcCtD
L-Arginine—Decreased appetite—Zonisamide—epilepsy syndrome	0.000209	0.00171	CcSEcCtD
L-Arginine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000207	0.0017	CcSEcCtD
L-Arginine—Hyperhidrosis—Lamotrigine—epilepsy syndrome	0.000205	0.00168	CcSEcCtD
L-Arginine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000205	0.00168	CcSEcCtD
L-Arginine—Nausea—Clobazam—epilepsy syndrome	0.000204	0.00167	CcSEcCtD
L-Arginine—Anorexia—Lamotrigine—epilepsy syndrome	0.000202	0.00166	CcSEcCtD
L-Arginine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000202	0.00165	CcSEcCtD
L-Arginine—Decreased appetite—Clonazepam—epilepsy syndrome	0.000202	0.00165	CcSEcCtD
L-Arginine—Decreased appetite—Phenytoin—epilepsy syndrome	0.0002	0.00164	CcSEcCtD
L-Arginine—Flushing—Pregabalin—epilepsy syndrome	0.000199	0.00163	CcSEcCtD
L-Arginine—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000199	0.00163	CcSEcCtD
L-Arginine—Hypoaesthesia—Gabapentin—epilepsy syndrome	0.000196	0.00161	CcSEcCtD
L-Arginine—Vomiting—Acetazolamide—epilepsy syndrome	0.000194	0.00159	CcSEcCtD
L-Arginine—Headache—Acetazolamide—epilepsy syndrome	0.000191	0.00157	CcSEcCtD
L-Arginine—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000191	0.00157	CcSEcCtD
L-Arginine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.00019	0.00156	CcSEcCtD
L-Arginine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000187	0.00153	CcSEcCtD
L-Arginine—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000185	0.00151	CcSEcCtD
L-Arginine—Nausea—Acetazolamide—epilepsy syndrome	0.000181	0.00149	CcSEcCtD
L-Arginine—Vomiting—Propofol—epilepsy syndrome	0.00018	0.00148	CcSEcCtD
L-Arginine—Rash—Propofol—epilepsy syndrome	0.000179	0.00147	CcSEcCtD
L-Arginine—Dermatitis—Propofol—epilepsy syndrome	0.000179	0.00146	CcSEcCtD
L-Arginine—Headache—Propofol—epilepsy syndrome	0.000178	0.00146	CcSEcCtD
L-Arginine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000177	0.00145	CcSEcCtD
L-Arginine—Vomiting—Midazolam—epilepsy syndrome	0.000176	0.00145	CcSEcCtD
L-Arginine—Haematuria—Topiramate—epilepsy syndrome	0.000176	0.00144	CcSEcCtD
L-Arginine—Rash—Midazolam—epilepsy syndrome	0.000175	0.00143	CcSEcCtD
L-Arginine—Dermatitis—Midazolam—epilepsy syndrome	0.000175	0.00143	CcSEcCtD
L-Arginine—Vomiting—Levetiracetam—epilepsy syndrome	0.000174	0.00143	CcSEcCtD
L-Arginine—Headache—Midazolam—epilepsy syndrome	0.000174	0.00142	CcSEcCtD
L-Arginine—Rash—Levetiracetam—epilepsy syndrome	0.000173	0.00142	CcSEcCtD
L-Arginine—SLC22A5—brain—epilepsy syndrome	0.000173	0.00331	CbGeAlD
L-Arginine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000173	0.00141	CcSEcCtD
L-Arginine—Headache—Levetiracetam—epilepsy syndrome	0.000172	0.00141	CcSEcCtD
L-Arginine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000171	0.0014	CcSEcCtD
L-Arginine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00017	0.00139	CcSEcCtD
L-Arginine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000169	0.00138	CcSEcCtD
L-Arginine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000169	0.00138	CcSEcCtD
L-Arginine—Nausea—Propofol—epilepsy syndrome	0.000169	0.00138	CcSEcCtD
L-Arginine—Vomiting—Fosphenytoin—epilepsy syndrome	0.000168	0.00138	CcSEcCtD
L-Arginine—Rash—Fosphenytoin—epilepsy syndrome	0.000167	0.00137	CcSEcCtD
L-Arginine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000167	0.00137	CcSEcCtD
L-Arginine—Headache—Fosphenytoin—epilepsy syndrome	0.000166	0.00136	CcSEcCtD
L-Arginine—Nausea—Midazolam—epilepsy syndrome	0.000165	0.00135	CcSEcCtD
L-Arginine—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000165	0.00135	CcSEcCtD
L-Arginine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000165	0.00135	CcSEcCtD
L-Arginine—Vomiting—Vigabatrin—epilepsy syndrome	0.000164	0.00134	CcSEcCtD
L-Arginine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000163	0.00134	CcSEcCtD
L-Arginine—Nausea—Levetiracetam—epilepsy syndrome	0.000163	0.00133	CcSEcCtD
L-Arginine—Rash—Vigabatrin—epilepsy syndrome	0.000163	0.00133	CcSEcCtD
L-Arginine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000162	0.00133	CcSEcCtD
L-Arginine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000162	0.00133	CcSEcCtD
L-Arginine—Headache—Vigabatrin—epilepsy syndrome	0.000162	0.00132	CcSEcCtD
L-Arginine—Vomiting—Diazepam—epilepsy syndrome	0.000161	0.00132	CcSEcCtD
L-Arginine—Anorexia—Valproic Acid—epilepsy syndrome	0.000161	0.00132	CcSEcCtD
L-Arginine—Rash—Diazepam—epilepsy syndrome	0.00016	0.00131	CcSEcCtD
L-Arginine—Dermatitis—Diazepam—epilepsy syndrome	0.00016	0.00131	CcSEcCtD
L-Arginine—Headache—Diazepam—epilepsy syndrome	0.000159	0.0013	CcSEcCtD
L-Arginine—Nausea—Fosphenytoin—epilepsy syndrome	0.000157	0.00129	CcSEcCtD
L-Arginine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000157	0.00128	CcSEcCtD
L-Arginine—Vomiting—Felbamate—epilepsy syndrome	0.000156	0.00128	CcSEcCtD
L-Arginine—Rash—Felbamate—epilepsy syndrome	0.000155	0.00127	CcSEcCtD
L-Arginine—Dermatitis—Felbamate—epilepsy syndrome	0.000155	0.00127	CcSEcCtD
L-Arginine—Headache—Felbamate—epilepsy syndrome	0.000154	0.00126	CcSEcCtD
L-Arginine—Flushing—Topiramate—epilepsy syndrome	0.000154	0.00126	CcSEcCtD
L-Arginine—Nausea—Vigabatrin—epilepsy syndrome	0.000153	0.00126	CcSEcCtD
L-Arginine—Vomiting—Zonisamide—epilepsy syndrome	0.000153	0.00125	CcSEcCtD
L-Arginine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000153	0.00125	CcSEcCtD
L-Arginine—Rash—Zonisamide—epilepsy syndrome	0.000152	0.00124	CcSEcCtD
L-Arginine—Dermatitis—Zonisamide—epilepsy syndrome	0.000152	0.00124	CcSEcCtD
L-Arginine—Nausea—Diazepam—epilepsy syndrome	0.000151	0.00124	CcSEcCtD
L-Arginine—Headache—Zonisamide—epilepsy syndrome	0.000151	0.00123	CcSEcCtD
L-Arginine—Tachycardia—Pregabalin—epilepsy syndrome	0.000149	0.00122	CcSEcCtD
L-Arginine—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000148	0.00121	CcSEcCtD
L-Arginine—Vomiting—Clonazepam—epilepsy syndrome	0.000147	0.00121	CcSEcCtD
L-Arginine—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000147	0.0012	CcSEcCtD
L-Arginine—Vomiting—Phenytoin—epilepsy syndrome	0.000146	0.0012	CcSEcCtD
L-Arginine—Rash—Clonazepam—epilepsy syndrome	0.000146	0.0012	CcSEcCtD
L-Arginine—Dermatitis—Clonazepam—epilepsy syndrome	0.000146	0.0012	CcSEcCtD
L-Arginine—Nausea—Felbamate—epilepsy syndrome	0.000146	0.0012	CcSEcCtD
L-Arginine—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000146	0.00119	CcSEcCtD
L-Arginine—Anorexia—Pregabalin—epilepsy syndrome	0.000145	0.00119	CcSEcCtD
L-Arginine—Headache—Clonazepam—epilepsy syndrome	0.000145	0.00119	CcSEcCtD
L-Arginine—Rash—Phenytoin—epilepsy syndrome	0.000145	0.00119	CcSEcCtD
L-Arginine—Dermatitis—Phenytoin—epilepsy syndrome	0.000145	0.00119	CcSEcCtD
L-Arginine—Rash—Oxcarbazepine—epilepsy syndrome	0.000144	0.00118	CcSEcCtD
L-Arginine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000144	0.00118	CcSEcCtD
L-Arginine—Headache—Phenytoin—epilepsy syndrome	0.000144	0.00118	CcSEcCtD
L-Arginine—Headache—Oxcarbazepine—epilepsy syndrome	0.000143	0.00118	CcSEcCtD
L-Arginine—Nausea—Zonisamide—epilepsy syndrome	0.000143	0.00117	CcSEcCtD
L-Arginine—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.00014	0.00115	CcSEcCtD
L-Arginine—Vomiting—Carbamazepine—epilepsy syndrome	0.00014	0.00115	CcSEcCtD
L-Arginine—Rash—Carbamazepine—epilepsy syndrome	0.000139	0.00114	CcSEcCtD
L-Arginine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000138	0.00113	CcSEcCtD
L-Arginine—Nausea—Clonazepam—epilepsy syndrome	0.000138	0.00113	CcSEcCtD
L-Arginine—Headache—Carbamazepine—epilepsy syndrome	0.000138	0.00113	CcSEcCtD
L-Arginine—Nausea—Phenytoin—epilepsy syndrome	0.000137	0.00112	CcSEcCtD
L-Arginine—Tachycardia—Gabapentin—epilepsy syndrome	0.000137	0.00112	CcSEcCtD
L-Arginine—Nausea—Oxcarbazepine—epilepsy syndrome	0.000136	0.00111	CcSEcCtD
L-Arginine—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
L-Arginine—Vomiting—Lamotrigine—epilepsy syndrome	0.000135	0.00111	CcSEcCtD
L-Arginine—Rash—Lamotrigine—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
L-Arginine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000134	0.0011	CcSEcCtD
L-Arginine—Anorexia—Gabapentin—epilepsy syndrome	0.000133	0.00109	CcSEcCtD
L-Arginine—Headache—Lamotrigine—epilepsy syndrome	0.000133	0.00109	CcSEcCtD
L-Arginine—Decreased appetite—Pregabalin—epilepsy syndrome	0.000133	0.00109	CcSEcCtD
L-Arginine—Nausea—Carbamazepine—epilepsy syndrome	0.000131	0.00107	CcSEcCtD
L-Arginine—Nausea—Lamotrigine—epilepsy syndrome	0.000126	0.00103	CcSEcCtD
L-Arginine—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000124	0.00102	CcSEcCtD
L-Arginine—Decreased appetite—Gabapentin—epilepsy syndrome	0.000122	0.000997	CcSEcCtD
L-Arginine—Tachycardia—Topiramate—epilepsy syndrome	0.000115	0.000941	CcSEcCtD
L-Arginine—Hyperhidrosis—Topiramate—epilepsy syndrome	0.000114	0.000933	CcSEcCtD
L-Arginine—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000112	0.000921	CcSEcCtD
L-Arginine—Anorexia—Topiramate—epilepsy syndrome	0.000112	0.00092	CcSEcCtD
L-Arginine—Vomiting—Valproic Acid—epilepsy syndrome	0.000107	0.000879	CcSEcCtD
L-Arginine—Rash—Valproic Acid—epilepsy syndrome	0.000106	0.000872	CcSEcCtD
L-Arginine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000106	0.000871	CcSEcCtD
L-Arginine—Headache—Valproic Acid—epilepsy syndrome	0.000106	0.000866	CcSEcCtD
L-Arginine—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000103	0.000845	CcSEcCtD
L-Arginine—Decreased appetite—Topiramate—epilepsy syndrome	0.000102	0.000839	CcSEcCtD
L-Arginine—Nausea—Valproic Acid—epilepsy syndrome	0.0001	0.000822	CcSEcCtD
L-Arginine—Vomiting—Pregabalin—epilepsy syndrome	9.7e-05	0.000795	CcSEcCtD
L-Arginine—Rash—Pregabalin—epilepsy syndrome	9.62e-05	0.000788	CcSEcCtD
L-Arginine—Dermatitis—Pregabalin—epilepsy syndrome	9.61e-05	0.000788	CcSEcCtD
L-Arginine—Headache—Pregabalin—epilepsy syndrome	9.56e-05	0.000783	CcSEcCtD
L-Arginine—Nausea—Pregabalin—epilepsy syndrome	9.06e-05	0.000743	CcSEcCtD
L-Arginine—Vomiting—Gabapentin—epilepsy syndrome	8.9e-05	0.000729	CcSEcCtD
L-Arginine—Rash—Gabapentin—epilepsy syndrome	8.82e-05	0.000723	CcSEcCtD
L-Arginine—Dermatitis—Gabapentin—epilepsy syndrome	8.81e-05	0.000722	CcSEcCtD
L-Arginine—Headache—Gabapentin—epilepsy syndrome	8.77e-05	0.000718	CcSEcCtD
L-Arginine—Hypersensitivity—Topiramate—epilepsy syndrome	8.67e-05	0.000711	CcSEcCtD
L-Arginine—Nausea—Gabapentin—epilepsy syndrome	8.31e-05	0.000681	CcSEcCtD
L-Arginine—Vomiting—Topiramate—epilepsy syndrome	7.49e-05	0.000613	CcSEcCtD
L-Arginine—Rash—Topiramate—epilepsy syndrome	7.42e-05	0.000608	CcSEcCtD
L-Arginine—Dermatitis—Topiramate—epilepsy syndrome	7.42e-05	0.000608	CcSEcCtD
L-Arginine—Headache—Topiramate—epilepsy syndrome	7.38e-05	0.000604	CcSEcCtD
L-Arginine—Nausea—Topiramate—epilepsy syndrome	6.99e-05	0.000573	CcSEcCtD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	2.01e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—epilepsy syndrome	2e-05	0.000147	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—GPX1—epilepsy syndrome	1.98e-05	0.000145	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NOS1—epilepsy syndrome	1.97e-05	0.000145	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ADRA2A—epilepsy syndrome	1.96e-05	0.000144	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—BCHE—epilepsy syndrome	1.96e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPP1R3C—epilepsy syndrome	1.96e-05	0.000144	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GBE1—epilepsy syndrome	1.96e-05	0.000144	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.95e-05	0.000143	CbGpPWpGaD
L-Arginine—NOS3—Disease—ST3GAL3—epilepsy syndrome	1.94e-05	0.000143	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—JUN—epilepsy syndrome	1.94e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—FYN—epilepsy syndrome	1.93e-05	0.000142	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—POMC—epilepsy syndrome	1.92e-05	0.000141	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.91e-05	0.00014	CbGpPWpGaD
L-Arginine—SLC22A4—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.89e-05	0.000139	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—SLC2A1—epilepsy syndrome	1.87e-05	0.000137	CbGpPWpGaD
L-Arginine—SLC16A10—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.86e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—YWHAZ—epilepsy syndrome	1.86e-05	0.000136	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.85e-05	0.000136	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT3—epilepsy syndrome	1.85e-05	0.000136	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PLCB1—epilepsy syndrome	1.85e-05	0.000135	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TH—epilepsy syndrome	1.84e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ASAH1—epilepsy syndrome	1.84e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR5—epilepsy syndrome	1.84e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR4—epilepsy syndrome	1.84e-05	0.000135	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLAUR—epilepsy syndrome	1.83e-05	0.000134	CbGpPWpGaD
L-Arginine—NOS2—Disease—EIF2AK2—epilepsy syndrome	1.82e-05	0.000134	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.8e-05	0.000132	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—STXBP1—epilepsy syndrome	1.79e-05	0.000131	CbGpPWpGaD
L-Arginine—ASL—Metabolism—POMC—epilepsy syndrome	1.76e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR10—epilepsy syndrome	1.76e-05	0.000129	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—ALB—epilepsy syndrome	1.75e-05	0.000129	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—NT5E—epilepsy syndrome	1.74e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALAD—epilepsy syndrome	1.74e-05	0.000128	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—SRC—epilepsy syndrome	1.74e-05	0.000128	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AGT—epilepsy syndrome	1.73e-05	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.7e-05	0.000125	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—APOE—epilepsy syndrome	1.7e-05	0.000125	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CDC42—epilepsy syndrome	1.69e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS2—Disease—PPIA—epilepsy syndrome	1.69e-05	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CACNA1A—epilepsy syndrome	1.66e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALDH7A1—epilepsy syndrome	1.66e-05	0.000122	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PLAU—epilepsy syndrome	1.65e-05	0.000121	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ST3GAL3—epilepsy syndrome	1.63e-05	0.000119	CbGpPWpGaD
L-Arginine—ASL—Metabolism—ALB—epilepsy syndrome	1.6e-05	0.000118	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.6e-05	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ADSL—epilepsy syndrome	1.59e-05	0.000117	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.59e-05	0.000116	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.57e-05	0.000116	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GLUL—epilepsy syndrome	1.56e-05	0.000115	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.56e-05	0.000114	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM2—epilepsy syndrome	1.54e-05	0.000113	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.54e-05	0.000113	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CACNA1D—epilepsy syndrome	1.54e-05	0.000113	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—HMOX1—epilepsy syndrome	1.54e-05	0.000113	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—epilepsy syndrome	1.54e-05	0.000113	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PRKCB—epilepsy syndrome	1.53e-05	0.000113	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.53e-05	0.000112	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CAT—epilepsy syndrome	1.51e-05	0.000111	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.51e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—epilepsy syndrome	1.51e-05	0.000111	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—FYN—epilepsy syndrome	1.5e-05	0.00011	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ABCB1—epilepsy syndrome	1.47e-05	0.000108	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.46e-05	0.000107	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—POMC—epilepsy syndrome	1.46e-05	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—YWHAZ—epilepsy syndrome	1.44e-05	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TXNRD1—epilepsy syndrome	1.44e-05	0.000105	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—epilepsy syndrome	1.42e-05	0.000104	CbGpPWpGaD
L-Arginine—SLC22A5—SLC-mediated transmembrane transport—ALB—epilepsy syndrome	1.42e-05	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Disease—EIF2AK2—epilepsy syndrome	1.42e-05	0.000104	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—epilepsy syndrome	1.4e-05	0.000103	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AQP1—epilepsy syndrome	1.39e-05	0.000102	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR3—epilepsy syndrome	1.39e-05	0.000102	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GPX1—epilepsy syndrome	1.37e-05	0.0001	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.36e-05	9.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR8—epilepsy syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NPY2R—epilepsy syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR1—epilepsy syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR9—epilepsy syndrome	1.33e-05	9.78e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—ALB—epilepsy syndrome	1.33e-05	9.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPIA—epilepsy syndrome	1.31e-05	9.61e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM4—epilepsy syndrome	1.31e-05	9.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM3—epilepsy syndrome	1.31e-05	9.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR2—epilepsy syndrome	1.28e-05	9.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DUSP4—epilepsy syndrome	1.28e-05	9.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLAU—epilepsy syndrome	1.28e-05	9.4e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—ALB—epilepsy syndrome	1.27e-05	9.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—KCNJ11—epilepsy syndrome	1.26e-05	9.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CHRM3—epilepsy syndrome	1.26e-05	9.25e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A1—epilepsy syndrome	1.25e-05	9.17e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—JUNB—epilepsy syndrome	1.24e-05	9.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM8—epilepsy syndrome	1.24e-05	9.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PGF—epilepsy syndrome	1.24e-05	9.1e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOS1—epilepsy syndrome	1.23e-05	9.03e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.2e-05	8.83e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AGT—epilepsy syndrome	1.2e-05	8.81e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.19e-05	8.75e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PRKCB—epilepsy syndrome	1.19e-05	8.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OPRD1—epilepsy syndrome	1.18e-05	8.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GNAO1—epilepsy syndrome	1.18e-05	8.68e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NOS2—epilepsy syndrome	1.18e-05	8.64e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—epilepsy syndrome	1.18e-05	8.63e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HBEGF—epilepsy syndrome	1.17e-05	8.62e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—epilepsy syndrome	1.16e-05	8.54e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.15e-05	8.47e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT3—epilepsy syndrome	1.15e-05	8.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM1—epilepsy syndrome	1.13e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PDYN—epilepsy syndrome	1.13e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR7—epilepsy syndrome	1.13e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CHRM1—epilepsy syndrome	1.13e-05	8.32e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—ADAM10—epilepsy syndrome	1.13e-05	8.26e-05	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—epilepsy syndrome	1.08e-05	7.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GFAP—epilepsy syndrome	1.07e-05	7.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GAL—epilepsy syndrome	1.07e-05	7.82e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP2—epilepsy syndrome	1.05e-05	7.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CHRM3—epilepsy syndrome	1.05e-05	7.73e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GRM5—epilepsy syndrome	1.05e-05	7.73e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CDC42—epilepsy syndrome	1.05e-05	7.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCG2—epilepsy syndrome	1.03e-05	7.54e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—POMC—epilepsy syndrome	1.01e-05	7.42e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.01e-05	7.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2C19—epilepsy syndrome	1e-05	7.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP11A1—epilepsy syndrome	9.95e-06	7.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BDKRB1—epilepsy syndrome	9.91e-06	7.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CHRM2—epilepsy syndrome	9.91e-06	7.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CX3CL1—epilepsy syndrome	9.91e-06	7.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—ALB—epilepsy syndrome	9.9e-06	7.26e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A1—epilepsy syndrome	9.7e-06	7.12e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GABBR1—epilepsy syndrome	9.64e-06	7.07e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—HES1—epilepsy syndrome	9.63e-06	7.07e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—JUNB—epilepsy syndrome	9.63e-06	7.06e-05	CbGpPWpGaD
L-Arginine—SLC22A4—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.61e-06	7.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS1—epilepsy syndrome	9.56e-06	7.01e-05	CbGpPWpGaD
L-Arginine—SLC16A10—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.45e-06	6.94e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FYN—epilepsy syndrome	9.36e-06	6.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—H2AFX—epilepsy syndrome	9.33e-06	6.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRH3—epilepsy syndrome	9.24e-06	6.78e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—ALB—epilepsy syndrome	9.22e-06	6.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HBEGF—epilepsy syndrome	9.12e-06	6.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OPRM1—epilepsy syndrome	9.1e-06	6.68e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—epilepsy syndrome	9.02e-06	6.62e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—YWHAZ—epilepsy syndrome	9e-06	6.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CYP2D6—epilepsy syndrome	8.98e-06	6.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT3—epilepsy syndrome	8.95e-06	6.57e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—epilepsy syndrome	8.78e-06	6.44e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—ADAM10—epilepsy syndrome	8.74e-06	6.41e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—CCR5—epilepsy syndrome	8.66e-06	6.35e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR3—epilepsy syndrome	8.59e-06	6.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ADRA2A—epilepsy syndrome	8.55e-06	6.27e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—BCHE—epilepsy syndrome	8.52e-06	6.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NPY—epilepsy syndrome	8.37e-06	6.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ATP2A2—epilepsy syndrome	8.37e-06	6.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CDC42—epilepsy syndrome	8.17e-06	5.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A1—epilepsy syndrome	8.12e-06	5.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL3—epilepsy syndrome	8.08e-06	5.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL2—epilepsy syndrome	8.08e-06	5.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HSPB1—epilepsy syndrome	8.08e-06	5.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CRH—epilepsy syndrome	8.08e-06	5.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—OXT—epilepsy syndrome	8.08e-06	5.93e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—epilepsy syndrome	8.06e-06	5.92e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—TSC2—epilepsy syndrome	8.05e-06	5.91e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PLCB1—epilepsy syndrome	8.03e-06	5.89e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TH—epilepsy syndrome	8.01e-06	5.87e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—epilepsy syndrome	7.88e-06	5.78e-05	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—epilepsy syndrome	7.72e-06	5.66e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSC1—epilepsy syndrome	7.51e-06	5.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTK2B—epilepsy syndrome	7.51e-06	5.51e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES1—epilepsy syndrome	7.48e-06	5.49e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—IL6ST—epilepsy syndrome	7.4e-06	5.43e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NTRK2—epilepsy syndrome	7.31e-06	5.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR2—epilepsy syndrome	7.31e-06	5.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SST—epilepsy syndrome	7.31e-06	5.36e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FYN—epilepsy syndrome	7.27e-06	5.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—H2AFX—epilepsy syndrome	7.24e-06	5.32e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DUSP6—epilepsy syndrome	7.24e-06	5.31e-05	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.22e-06	5.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.15e-06	5.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLAT—epilepsy syndrome	7.12e-06	5.22e-05	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—epilepsy syndrome	7.06e-06	5.18e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—epilepsy syndrome	7e-06	5.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—YWHAZ—epilepsy syndrome	6.99e-06	5.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL12—epilepsy syndrome	6.87e-06	5.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—BDKRB2—epilepsy syndrome	6.87e-06	5.04e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—epilepsy syndrome	6.82e-06	5e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CNR1—epilepsy syndrome	6.74e-06	4.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUNB—epilepsy syndrome	6.74e-06	4.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—CCR5—epilepsy syndrome	6.72e-06	4.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PLCB1—epilepsy syndrome	6.72e-06	4.93e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—HMOX1—epilepsy syndrome	6.68e-06	4.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CAT—epilepsy syndrome	6.59e-06	4.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HTR7—epilepsy syndrome	6.58e-06	4.83e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ABCB1—epilepsy syndrome	6.41e-06	4.71e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HBEGF—epilepsy syndrome	6.39e-06	4.69e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT3—epilepsy syndrome	6.27e-06	4.6e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—TSC2—epilepsy syndrome	6.25e-06	4.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ADAM10—epilepsy syndrome	6.12e-06	4.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—epilepsy syndrome	6.12e-06	4.49e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—FGF2—epilepsy syndrome	5.98e-06	4.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GPX1—epilepsy syndrome	5.96e-06	4.37e-05	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—epilepsy syndrome	5.85e-06	4.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—S100B—epilepsy syndrome	5.79e-06	4.25e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—IL6ST—epilepsy syndrome	5.75e-06	4.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SOCS3—epilepsy syndrome	5.73e-06	4.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CDC42—epilepsy syndrome	5.72e-06	4.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOS2—epilepsy syndrome	5.7e-06	4.18e-05	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—epilepsy syndrome	5.6e-06	4.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AVP—epilepsy syndrome	5.54e-06	4.06e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—MTOR—epilepsy syndrome	5.45e-06	4e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—epilepsy syndrome	5.4e-06	3.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES1—epilepsy syndrome	5.24e-06	3.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AGT—epilepsy syndrome	5.23e-06	3.84e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—epilepsy syndrome	5.12e-06	3.76e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FYN—epilepsy syndrome	5.09e-06	3.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—H2AFX—epilepsy syndrome	5.07e-06	3.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MEF2C—epilepsy syndrome	5.06e-06	3.72e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.89e-06	3.59e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NGF—epilepsy syndrome	4.84e-06	3.55e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCR5—epilepsy syndrome	4.71e-06	3.45e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—FGF2—epilepsy syndrome	4.65e-06	3.41e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HTR2A—epilepsy syndrome	4.61e-06	3.38e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—POMC—epilepsy syndrome	4.4e-06	3.23e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSC2—epilepsy syndrome	4.38e-06	3.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGT—epilepsy syndrome	4.37e-06	3.21e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—epilepsy syndrome	4.37e-06	3.2e-05	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—epilepsy syndrome	4.35e-06	3.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—epilepsy syndrome	4.28e-06	3.14e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—MTOR—epilepsy syndrome	4.23e-06	3.1e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—epilepsy syndrome	4.2e-06	3.08e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—epilepsy syndrome	4.19e-06	3.08e-05	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—epilepsy syndrome	4.05e-06	2.97e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRKCB—epilepsy syndrome	4.04e-06	2.96e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IL6ST—epilepsy syndrome	4.02e-06	2.95e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ALB—epilepsy syndrome	4.01e-06	2.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—POMC—epilepsy syndrome	3.68e-06	2.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCL2—epilepsy syndrome	3.6e-06	2.64e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—epilepsy syndrome	3.51e-06	2.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—epilepsy syndrome	3.39e-06	2.49e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—FGF2—epilepsy syndrome	3.25e-06	2.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—RELA—epilepsy syndrome	3.02e-06	2.22e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MTOR—epilepsy syndrome	2.96e-06	2.17e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—epilepsy syndrome	2.72e-06	2e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—epilepsy syndrome	2.71e-06	1.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JUN—epilepsy syndrome	2.65e-06	1.94e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—epilepsy syndrome	2.57e-06	1.89e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—epilepsy syndrome	2.37e-06	1.74e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—epilepsy syndrome	2.31e-06	1.7e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—epilepsy syndrome	2.11e-06	1.55e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—epilepsy syndrome	1.76e-06	1.29e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—epilepsy syndrome	1.48e-06	1.08e-05	CbGpPWpGaD
